Aspirin/warfarin no more effective than aspirin alone in preventing second MI -- Lancet.
This article was originally published in The Tan Sheet
ASPIRIN/WARFARIN COMBO NOT RECOMMENDED FOR SECOND MI PREVENTION because it is no more effective than aspirin alone, Coumadin Aspirin Reinfarction Study (CARS) investigators conclude in a study published in the Aug. 9 Lancet. "Low, fixed-dose warfarin (1 mg or 3 mg) combined with low-dose aspirin (80 mg) in patients who have had myocardial infarction does not provide clinical benefit beyond that achievable with 160 mg aspirin monotherapy," the CARS group states. Valentin Fuster, MD/PhD, Mount Sinai Hospital, New York City, chaired the CARS writing and steering committee, which oversaw the design and conduct of the randomized, double-blind trial. The study was funded by Du Pont Merck Pharmaceutical.
You may also be interested in...
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC